Clinical Trial Update: Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study investigating the pharmacokinetic interaction between itraconazole and rilapladib in healthy volunteers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Itraconazole (Itraconazole)
• Rilapladib (rilapladib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alzheimer's Disease | Phase 1 | Status: WITHDRAWN